穩健醫療(300888.SZ):高端敷料2024年前三季度累計實現銷售收入5.7億元,佔醫療業務收入比重的21%,同比增長34%,增長勢頭良好
格隆匯12月9日丨穩健醫療(300888.SZ)在投資者互動平台表示,高端敷料是公司醫療業務的重點品類,2024年前三季度累計實現銷售收入5.7億元,佔醫療業務收入比重的21%,同比增長34%,增長勢頭良好。目前該品類的銷售收入絕大部分由境外市場貢獻,因為國內仍處於市場教育階段。境外市場分為兩塊:第一塊是OEM貼牌業務,該業務比較成熟,未來有望通過拓展新市場新客户、老客户新品類推動其增長;第二塊是跨境電商業務,鑑於高端敷料在海外普及性較高,公司在跨境平台亞馬遜上進行銷售,表現良好,平台上品類排名持續領先,公司將努力提升海外C端市場的份額佔比。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.